Table 2.
Variable | HR* | 95% CI | p-value | |
---|---|---|---|---|
BMI, continuous(kg/m2) | 1.03 | 1.00–1.07 | 0.042 | |
Log iPSA(ng/mL) | 2.02 | 1.60–2.52 | <0.001 | |
Age(years) | 1.00 | 0.98–1.02 | 0.992 | |
ADT Use(yes vs no) | 0.74 | 0.47–1.17 | 0.192 | |
Comorbidities(yes vs no) | ||||
Diabetes | 1.09 | 0.71–1.69 | 0.691 | |
Hypertension | 1.17 | 0.83–1.66 | 0.373 | |
Heart Disease | 0.80 | 0.51–1.25 | 0.322 |
BF, biochemical failure; BMI, body mass index; HR, hazard ratio; ADT, androgen deprivation therapy; iPSA, pre-treatment prostate specific antigen.
Hazard ratios are from a single stratified Cox proportional hazards model, adjusted for T-stage and Gleason score as stratification variables.